These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 1123988

  • 1. [Therapy of chronic peripheral arterial occlusive diseases with snake venom enzyme Arwin].
    Ehrly AM.
    Med Welt; 1975 Mar 07; 26(10):446-55. PubMed ID: 1123988
    [No Abstract] [Full Text] [Related]

  • 2. [Conservative therapy of chronic arterial occlusive diseases using subcutaneous administration of the rheologically effective snake venom Arwin].
    Ehrly AM, Breddin K.
    Verh Dtsch Ges Kreislaufforsch; 1974 Mar 07; 40():243-5. PubMed ID: 4450660
    [No Abstract] [Full Text] [Related]

  • 3. [Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].
    Rosendo A, Sala Planell E, Latorre J, Marinello J, Olba L, Rutllant ML.
    Rev Clin Esp; 1982 Mar 15; 164(5):313-6. PubMed ID: 7100546
    [No Abstract] [Full Text] [Related]

  • 4. [Hemorrheological factors in the developmental stages of peripheral arterial occlusive diseases].
    Artale F, Sergio G, Cramarossa L, Giunti P, Francisci A, Perego MA.
    Ric Clin Lab; 1983 Mar 15; 13 Suppl 3():411-5. PubMed ID: 6673022
    [Abstract] [Full Text] [Related]

  • 5. [Defibrination with the snake venom enzyme arwin in peripheral arterial obstructive disease. Possibilities and limitations (author's transl)].
    Böhme H, Schmidt P, Hüttel E.
    MMW Munch Med Wochenschr; 1978 Nov 10; 120(45):1501-4. PubMed ID: 101819
    [Abstract] [Full Text] [Related]

  • 6. [Improvement of flow properties of blood: a new principle for drug therapy of chronic peripheral arterial vascular disorders].
    Ehrly AM.
    Vasa Suppl; 1973 Nov 10; 1():1-18. PubMed ID: 4517911
    [No Abstract] [Full Text] [Related]

  • 7. [Hemorheologic risk profile in peripheral arterial occlusive disease, diabetic angiopathy and essential arterial hypertension].
    Sternitzky R, Wiederhold KF, Hänsgen K, Jäger H, Turowski A, Voigt H.
    Vasa Suppl; 1991 Nov 10; 32():325-31. PubMed ID: 1771526
    [No Abstract] [Full Text] [Related]

  • 8. [Hemorheologic and blood coagulation studies in 94 patients with chronic obstructive peripheral arterial disease].
    Bracale G, Selvetella L, Bernardo B, Scalise E, Bertone L, De Caterina M.
    Ric Clin Lab; 1985 Nov 10; 15 Suppl 1():195-203. PubMed ID: 3929368
    [Abstract] [Full Text] [Related]

  • 9. [Effect of benfurodil hemiscucinate (Eucilat) on various hemorheologic parameters in patients with chronic peripheral obstructive arteriopathies].
    Mozzi E, Annoni F, Chiurazzi D, Rossi R, Pacini F, Martini A.
    Minerva Cardioangiol; 1984 Mar 10; 32(3):141-9. PubMed ID: 6374499
    [No Abstract] [Full Text] [Related]

  • 10. [Regional study of the principal hemorheological factors in peripheral obstructive arteriopathy. I].
    Artale F, Sergio G, Espureo M, Giunti P, Francisci A, Perego MA.
    Minerva Cardioangiol; 1981 Mar 10; 29(7-8):367-74. PubMed ID: 7279237
    [No Abstract] [Full Text] [Related]

  • 11. [Blood rheological changes and their clinical significance in chronic arterial obstructive disease].
    Sternitzky R, Seige K.
    Z Gesamte Inn Med; 1983 Jan 01; 38(1):1-7. PubMed ID: 6342278
    [Abstract] [Full Text] [Related]

  • 12. [Blood fluidity in essential hypertension, arterial occlusive disease and diabetic angiopathies].
    Sternitzky R, Hänsgen K, Podhaisky H.
    Z Gesamte Inn Med; 1991 Nov 01; 46(16):610-4. PubMed ID: 1792802
    [Abstract] [Full Text] [Related]

  • 13. [Combination hemodilution and defibrinogenating therapy in chronic arterial occlusive diseases].
    Ehrly AM, Saeger-Lorenz K.
    Verh Dtsch Ges Kreislaufforsch; 1977 Nov 01; 43():332-3. PubMed ID: 349931
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of an infusion of piribedil in normal subjects and in patients with peripheral obliterating arterial disease on the blood flow of the lower limbs and on blood, plasma and serum viscosity].
    Forconi S, Guerrini M, Agnusdei D, Di Perri T.
    Minerva Med; 1976 May 19; 67(25):1671-80. PubMed ID: 934519
    [No Abstract] [Full Text] [Related]

  • 15. [Experiences with arwin in combination with thrombolytic therapy].
    Keil-Kuri E, Hess H.
    Verh Dtsch Ges Inn Med; 1974 May 19; 80():1470-2. PubMed ID: 4454460
    [No Abstract] [Full Text] [Related]

  • 16. [Effects of pentoxifylline on blood viscosity and peripheral hemodynamics in patients with peripheral occlusive arteriopathies].
    Guerrini M, Pecchi S, Rossi C, Cappelli R, Pieragalli D, Acciavatti A.
    Ric Clin Lab; 1981 May 19; 11 Suppl 1():265-79. PubMed ID: 7188114
    [No Abstract] [Full Text] [Related]

  • 17. A new approach in the treatment of peripheral arterial occlusions: defibrination with arvin.
    Ehringer H, Dudczak R, Lechner K.
    Angiology; 1974 Apr 19; 25(4):279-89. PubMed ID: 4818725
    [No Abstract] [Full Text] [Related]

  • 18. [Improvement of blood viscosity through Arvin].
    Ehrly AM, Breddin K.
    Verh Dtsch Ges Inn Med; 1972 Apr 19; 78():620-4. PubMed ID: 4677224
    [No Abstract] [Full Text] [Related]

  • 19. [Hemorheologic studies for evaluating microcirculation in patients with peripheral arterial circulatory disorders and diabetes mellitus].
    Sternitzky R, Hänsgen K, Podhaisky H, Frank I, Klare M, Preuss EG.
    Z Gesamte Inn Med; 1986 Oct 01; 41(19):539-42. PubMed ID: 3811440
    [Abstract] [Full Text] [Related]

  • 20. [Hemorrheology, microcirculation and oxygenation. Physiopathological and therapeutic aspects].
    Ehrly M.
    Rev Fr Gynecol Obstet; 1991 Feb 25; 86(2 Pt 2):131-8. PubMed ID: 1767162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.